ChemoMetec wants to increase pace of US growth
![Foto: ChemoMetec, PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article7034353.ece/ALTERNATES/schema-16_9/Michael%2520Eising.jpg)
ChemoMetec is currently in the process of establishing a direct sales channel in Europe, following great success with a similar initiative on the American market. Meanwhile, the Danish cell count company is preparing to take things to “the next level” in the US, CEO Michael Eising tells MedWatch.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
ChemoMetec chief: Clear expectation of continued growth
For abonnenter
ChemoMetec CEO: A result of the strategy
For abonnenter
New ChemoMetec CEO: ”You have to prioritize”
For abonnenter